That high-grade gliomas (including GBM) tend to avoid high RNF8 expression was further validated at the protein level using glioma microarray (~4-fold less; score +++: 4.3% high-grade vs 16.9% low-grade) (Fig. 6B, C). The gene discussed is RNF8; the disease is central nervous system cancer.